Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments.
J Neurosci Res. 2020 Dec;98(12):2496-2509. doi: 10.1002/jnr.24716. Epub 2020 Sep 2.
J Neurosci Res. 2020.
PMID: 32881145
Cannabinoids in the Cardiovascular System.
Ho WSV, Kelly MEM.
Ho WSV, et al.
Adv Pharmacol. 2017;80:329-366. doi: 10.1016/bs.apha.2017.05.002. Epub 2017 Jul 3.
Adv Pharmacol. 2017.
PMID: 28826540
Review.
Item in Clipboard
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor.
Laprairie RB, Kulkarni PM, Deschamps JR, Kelly MEM, Janero DR, Cascio MG, Stevenson LA, Pertwee RG, Kenakin TP, Denovan-Wright EM, Thakur GA.
Laprairie RB, et al.
ACS Chem Neurosci. 2017 Jun 21;8(6):1188-1203. doi: 10.1021/acschemneuro.6b00310. Epub 2017 Feb 7.
ACS Chem Neurosci. 2017.
PMID: 28103441
Item in Clipboard
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Bagher AM, Laprairie RB, Kelly ME, Denovan-Wright EM.
Bagher AM, et al.
Mol Pharmacol. 2016 Jun;89(6):652-66. doi: 10.1124/mol.116.103465. Epub 2016 Apr 6.
Mol Pharmacol. 2016.
PMID: 27053685
Item in Clipboard
Cite
Cite